Development of services for an innovative collaborative model the Swedish Model for Primary Care to China
| Reference number | |
| Coordinator | STIFTELSEN SWECARE |
| Funding from Vinnova | SEK 700 000 |
| Project duration | November 2016 - April 2017 |
| Status | Completed |
Important results from the project
The purpose is to meet foreign demand for comprehensive healthcare solutions, with China as a pilot country. The goals of developing a collaborative model, anchoring it with stakeholders, exploring opportunities for funding and establishing an organization for this have all been achieved. A collaborative model has been developed, for communication, legal structure and business model and anchored among interested companies in Sweden. The offer has been presented in China, resulting in business-related discussions. Several funding opportunities have been investigated.
Expected long term effects
Expected effects and results were greater growth opportunities for Swedish companies through joint offer and support. The project result was to validate business opportunities and assess how the players can jointly deliver, as well as to create a platform for the consortium. The results have been achieved - a platform is created with a number of companies having signed an NDA, the consortium and its solutions have been presented and validated in China, resulting in a number of leads that are now actively followed up. Customized complete solutions can now be developed according to demand.
Approach and implementation
The implementation plan has been followed. A project team was formed at the start of the project, shortly afterwards an AB was founded. Getting by-in from Swedish actors began at the year end, as well as with important stakeholders - in addition to companies also service providers, healthcare advisors in business development and China experience. The business offer was developed at the beginning of the year, as was the company´s basic structure. Following that, validation of business opportunities in China, especially during a trip in late March, with follow-up in April and beyond.